Zinman B, Gerich J, Buse J, et al
7 Exenatide (Byetta, Bydureon): Primarily used to manage type 2 diabetes, exenatide is available under two brand names in the US
In newer phase 3 trials, researchers used doses like 2 mg, 4 mg, 6 mg, 9 mg, and 12 mg, still taken once a week and increased slowly over time
This tri-agonist mechanism distinguishes it from currently approved agents such as semaglutide or tirzepatide
If a provider publishes processing timeframes and verification steps up front, that is a positive signal
We also offer high-value niche products like Hospital Indemnity and Dental/Vision/Hearing (DVH) to help you round out their coverage and increase your per-client revenue